Pura Vida Investments’s Standard BioTools LAB Stock Holding History

Pura Vida Investments’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300,000	Closed	-$1.39M	–	112
2019 Q3	$1.39M	Buy	+300,000	New	+$2.36M	0.24%	75
2018 Q4	–	Sell	-150,000	Closed	-$1.12M	–	92
2018 Q3	$1.12M	Buy	+150,000	New	+$1.07M	0.24%	81

Other funds holding LAB

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Pura Vida Investments's LAB Position: Q4 2022 in Review

Pura Vida Investments sold out of Standard BioTools (LAB) in Q4 2022, closing a stake of 253,132 shares — an estimated $278K sold.

Pura Vida Investments first reported a position in LAB in Q1 2016 and held it in 12 quarters. The position peaked at $6.04M in Q3 2020. 68 funds tracked by Wall St. Rank hold LAB as of Q4 2022.

Pura Vida Investments reported no remaining Standard BioTools position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 253,132 Standard BioTools shares in Q4 2022, an estimated $278K.
Pura Vida Investments first reported a position in Standard BioTools in Q1 2016 and held it in 12 quarters.
Pura Vida Investments's Standard BioTools position peaked at $6.04M in Q3 2020.
68 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.